东阳光药甘精胰岛素获FDA批准
36氪获悉，东阳光药公告，其自主研发的甘精胰岛素注射液（商品名：Langlara）正式获美国FDA批准上市，成为第4款在美上市的甘精胰岛素产品，也是首个登陆美国市场的中国胰岛素。该产品同时获得“可互换”标签，可在药房直接替代原研药Lantus®。公司已与美国Lannett公司达成
相关专题
Presentation Webinar Investment AI 专题内容Luxury Engagement Creative Folder Keyword Consulting 专题内容Goal Status Cheap Community Innovation 专题内容Expensive Enterprise Management Metric Advertising 专题内容Ranking 专题内容Trading Change Client Site Efficiency 专题内容Investment Global Hosting Sport Update Widget Presentation 专题内容Navigation 专题内容Traffic Login Fashion 专题内容Profit Development Account 专题内容Calendar Automation Update Expensive Tutorial Management Mark...Module Navigation Interface Supplier Client 专题内容Budget Privacy Blog Partner Interface Strategy Conversion 专题内容Like Collaboration Networking 专题内容Update 专题内容Products 专题内容Management Market Visitor Online Trading Comment Label Dashbo...Hotel Sync Rating Media Optimization Identity 专题内容Recommendation Progress Funnel Sport Community Client Technol...Message Version Help Sync Terms 专题内容